PharmaResources (Shanghai) Co. Ltd. A (301230) — Cash Flow Reinvestment Rate
PharmaResources (Shanghai) Co. Ltd. A (301230) has a Cash Flow Reinvestment Rate of 0.32x as of December 2025, reinvesting CN¥43.51 Million (capex CN¥43.32 Million plus investments CN¥-194.62K) from operating cash flow of CN¥135.51 Million. Explore 301230 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
PharmaResources (Shanghai) Co. Ltd. A Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for PharmaResources (Shanghai) Co. Ltd. A across 6 annual periods. Also explore PharmaResources (Shanghai) Co. Ltd. A (301230) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for PharmaResources (Shanghai) Co. Ltd. A (2020–2025)
Year-by-year capital reinvestment analysis for PharmaResources (Shanghai) Co. Ltd. A. For live market cap and broader valuation context, see PharmaResources (Shanghai) Co. Ltd. A (301230) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | CN¥43.51 Million | CN¥135.51 Million | CN¥43.32 Million | ▼ -85.1% |
| 2024 | 2.15x | CN¥173.84 Million | CN¥80.86 Million | CN¥109.40 Million | ▼ -94.6% |
| 2023 | 39.82x | CN¥830.55 Million | CN¥20.86 Million | CN¥248.27 Million | ▲ +1445.8% |
| 2022 | 2.58x | CN¥255.77 Million | CN¥99.29 Million | CN¥123.97 Million | ▲ +48.5% |
| 2021 | 1.73x | CN¥182.37 Million | CN¥105.12 Million | CN¥92.12 Million | ▲ +83.6% |
| 2020 | 0.94x | CN¥51.46 Million | CN¥54.45 Million | CN¥33.51 Million | — |